[Pefloxacin (Abaktal)--efficacy in treating severe infections, optimization of treatment based on pharmacokinetic and pharmacodynamic parameters].
Research Centre of Drug Evaluation, National Research Centre of Antibiotics, Moscow.
S V
SV
Budanov
A N
AN
Vasil'ev
L B
LB
Smirnov
D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015366:Pefloxacin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D015366:Pefloxacin